NL-OMON37702尚未招募2 期
Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin for the Treatment of Metastatic Breast Cancer to the Liver: a pilot study - Chemoembolization with Doxorubicin for Metastatic Breast Cancer .
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with biopsy proven liver dominant ( over 50% volume) metastasis of breast carcinoma
排除标准
- •1: significant extrahepatic disease representing an eminent life-threatening outcome
- •2: more than 75% of hepatic parenchymal involvement
研究者
相似试验
进行中（未招募）
不适用
DEBDOX for liver metastases in breast carcinomaEUCTR2012-000973-22-NL
招募中
不适用
TRENDY trialPatients diagnosed with HCC, Child-Pugh grade A, one tumor 𕟮cm, and 󖾆 years old.NL-OMON28819Erasmus MCDepartment of Radiotherapy100
招募中
2 期
Transarterial Chemoembolization with Drug-Eluting Beads (standard arm) versus Stereotactic Body Radiation Therapy (experimental arm) for hepatocellular carcinoma: A multicenter randomized phase II trial *The TRENDY trial*hepatocellular carcinomaNL-OMON44103Erasmus MC, Universitair Medisch Centrum Rotterdam64
已完成
不适用
The Impact of Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinoma: A Single Center ExperienceHepatocellular carcinomaBCLC stage CBCLC stage CTACETransarterial ChemoembolizationHepatocellular carcinomaTCTR20150221001Rajavithi Hospital44
已完成
2 期
Phase II trial of Transarterial Chemoembolization using Drug-eluting bead for advanced HCC refractory to Lipiodol-TACEadvanced hepatocellular carcinomaJPRN-UMIN000015463Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization24